Effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetes [1]

Atherosclerosis

Volumn 183, Issue 2, 2005, Pages 367-368

  Stulc, Tomas ^a   Kasalova, Zdislava ^a   Krejci, Hana ^a   Dolezalova, Radka ^a   Ceska, Richard ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Diabetes mellitus; Homocysteine; Renal function; Rosiglitazone

Indexed keywords

FIBRIC ACID DERIVATIVE; HOMOCYSTEINE; METFORMIN; ROSIGLITAZONE; SULFONYLUREA;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FUNCTION; LETTER; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TURBIDIMETRY;

BIOLOGICAL MARKERS; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; HOMOCYSTEINE; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY; MALE; MIDDLE AGED; THIAZOLIDINEDIONES;

EID: 27644562181     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.08.012     Document Type: Letter

References (4)

1. M. deLorgeril, P. Salen, F. Paillard, P. Lacan, and G. Richard Lipid-lowering drugs and homocysteine Lancet 353 1999 209 210
2. T. Stulc, V. Melenovsky, B. Grauova, V. Kozich, and Ceska R Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy Nutrition 17 2001 721 723
3. C. Hottelart, N.E. Esper, F. Rose, J.M. Archard, and A. Fournier Fenofibrate increases creatininemia by increasing metabolic production of creatinine Nephron 92 2002 536 541
4. L.M. Stead, K.P. Au, R.L. Jacobs, M.E. Brosnan, and J.T. Brosnan Methylation demand and homocysteine metabolism: effects of dietary provision of creatinine and guanidinoacetate Am J Physiol Endocrinol Meta 281 2001 1095 1100